Attachment A.xlsx
XLSX spreadsheet 60 KB Posted
- Attached to
- 6550-- Testing for IHC, ISH, FISH, NGS and Flow Cytometry Federal contract opportunity
- Solicitation number
- 36C26226Q0410
About this file
This is a pricing schedule (Attachment A) for a federal solicitation requiring testing services for immunohistochemistry (IHC), in situ hybridization (ISH), fluorescence in situ hybridization (FISH), next-generation sequencing (NGS), and flow cytometry. The schedule lists 157 contract line items (CLINs) organized across a base period and four option periods, all supplied by NeoGenomics as the specified manufacturer.
The deliverables encompass a comprehensive range of pathology testing services, including individual stains and assays (such as H&E, HER2 Breast/Gastric, PD-L1 variants for NSCLC and other indications, mismatch repair panels, and various immunologic markers), as well as multi-stain panels and molecular testing including gene rearrangement analyses and mutation analyses. Quantities vary by service type, ranging from 2 to 66 units across the CLINs. The pricing columns are currently blank (showing "$-0" and "0" values), indicating this is a template awaiting price submissions from the contractor. The schedule maintains identical line items and quantities across the base period and all four option years, suggesting a stable service requirement throughout the potential contract term. The solicitation is issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Attachment B-SOW.pdf | ||
| RFQ doc.pdf | ||
| 36C26226Q0410.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
1. Base
| CLIN | Brand Name | Brand Name Nomenclature | Manufacturer Part Number | Salient Characteristics | Equivalent Brand | Equivalent Nomenclature | Equivalent Part Number | Equivalent Description Matching Salient Characteristics and/or location of information regarding equal capability | Quantity | Unit Price | Extended Price |
| 1 | (T) DDIT3 (CHOP)(12q13) | NEOGENOMICS | (T) DDIT3 (CHOP)(12q13) | See SOW | 2 | $ - 0 | |||||
| 2 | (T) H&E | NEOGENOMICS | (T) H&E | See SOW | 11 | $ - 0 | |||||
| 3 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 3 | $ - 0 | |||||
| 4 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 5 | (T) MDM2 | NEOGENOMICS | (T) MDM2 | See SOW | 8 | $ - 0 | |||||
| 6 | (P) AML MRD Flow Panel | NEOGENOMICS | (P) AML MRD Flow Panel | See SOW | 2 | $ - 0 | |||||
| 7 | (P) Amyloid A & P | NEOGENOMICS | (P) Amyloid A & P | See SOW | 3 | $ - 0 | |||||
| 8 | (P) Breast Panel (2 Stain) | NEOGENOMICS | (P) Breast Panel (2 Stain) | See SOW | 4 | $ - 0 | |||||
| 9 | (P) Breast Panel (3 Stain) | NEOGENOMICS | (P) Breast Panel (3 Stain) | See SOW | 4 | $ - 0 | |||||
| 10 | (P) Breast Panel (4 Stain) | NEOGENOMICS | (P) Breast Panel (4 Stain) | See SOW | 2 | $ - 0 | |||||
| 11 | (P) HPV RNA ISH Panel | NEOGENOMICS | (P) HPV RNA ISH Panel | See SOW | 8 | $ - 0 | |||||
| 12 | (P) Mismatch Repair (MMR) IHC Panel Qualitative | NEOGENOMICS | (P) Mismatch Repair (MMR) IHC Panel Qualitative | See SOW | 3 | $ - 0 | |||||
| 13 | (T) AFP | NEOGENOMICS | (T) AFP | See SOW | 4 | $ - 0 | |||||
| 14 | (T) Albumin RNA ISH | NEOGENOMICS | (T) Albumin RNA ISH | See SOW | 3 | $ - 0 | |||||
| 15 | (T) ALK (D5F3) | NEOGENOMICS | (T) ALK (D5F3) | See SOW | 4 | $ - 0 | |||||
| 16 | (T) ALK-1 (for Heme cases) | NEOGENOMICS | (T) ALK-1 (for Heme cases) | See SOW | 17 | $ - 0 | |||||
| 17 | (T) AR | NEOGENOMICS | (T) AR | See SOW | 2 | $ - 0 | |||||
| 18 | (T) AR Qualitative | NEOGENOMICS | (T) AR Qualitative | See SOW | 2 | $ - 0 | |||||
| 19 | (T) Arginase 1 | NEOGENOMICS | (T) Arginase 1 | See SOW | 12 | $ - 0 | |||||
| 20 | (T) BOB1 | NEOGENOMICS | (T) BOB1 | See SOW | 2 | $ - 0 | |||||
| 21 | (T) CA19.9 | NEOGENOMICS | (T) CA19.9 | See SOW | 2 | $ - 0 | |||||
| 22 | (T) Calcitonin | NEOGENOMICS | (T) Calcitonin | See SOW | 2 | $ - 0 | |||||
| 23 | (T) Calponin | NEOGENOMICS | (T) Calponin | See SOW | 2 | $ - 0 | |||||
| 24 | (T) Calretinin | NEOGENOMICS | (T) Calretinin | See SOW | 2 | $ - 0 | |||||
| 25 | (T) CD1a | NEOGENOMICS | (T) CD1a | See SOW | 3 | $ - 0 | |||||
| 26 | (T) CD2 | NEOGENOMICS | (T) CD2 | See SOW | 2 | $ - 0 | |||||
| 27 | (T) CD14 | NEOGENOMICS | (T) CD14 | See SOW | 2 | $ - 0 | |||||
| 28 | (T) CD15 | NEOGENOMICS | (T) CD15 | See SOW | 2 | $ - 0 | |||||
| 29 | (T) CD23 | NEOGENOMICS | (T) CD23 | See SOW | 4 | $ - 0 | |||||
| 30 | (T) CD25 | NEOGENOMICS | (T) CD25 | See SOW | 4 | $ - 0 | |||||
| 31 | (T) CD33 | NEOGENOMICS | (T) CD33 | See SOW | 2 | $ - 0 | |||||
| 32 | (T) CD42b | NEOGENOMICS | (T) CD42b | See SOW | 4 | $ - 0 | |||||
| 33 | (T) CD44 | NEOGENOMICS | (T) CD44 | See SOW | 5 | $ - 0 | |||||
| 34 | (T) CD61 | NEOGENOMICS | (T) CD61 | See SOW | 9 | $ - 0 | |||||
| 35 | (T) CD71 | NEOGENOMICS | (T) CD71 | See SOW | 4 | $ - 0 | |||||
| 36 | (T) CD79a | NEOGENOMICS | (T) CD79a | See SOW | 7 | $ - 0 | |||||
| 37 | (T) CD117 cKIT | NEOGENOMICS | (T) CD117 cKIT | See SOW | 3 | $ - 0 | |||||
| 38 | (T) CD123 | NEOGENOMICS | (T) CD123 | See SOW | 8 | $ - 0 | |||||
| 39 | (T) CD163 | NEOGENOMICS | (T) CD163 | See SOW | 3 | $ - 0 | |||||
| 40 | (T) CEA (Poly) | NEOGENOMICS | (T) CEA (Poly) | See SOW | 3 | $ - 0 | |||||
| 41 | (T) CK 7 | NEOGENOMICS | (T) CK 7 | See SOW | 7 | $ - 0 | |||||
| 42 | (T) CK 19 | NEOGENOMICS | (T) CK 19 | See SOW | 9 | $ - 0 | |||||
| 43 | (T) CK OSCAR | NEOGENOMICS | (T) CK OSCAR | See SOW | 7 | $ - 0 | |||||
| 44 | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | NEOGENOMICS | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | See SOW | 3 | $ - 0 | |||||
| 45 | (T) CMV by IHC | NEOGENOMICS | (T) CMV by IHC | See SOW | 28 | $ - 0 | |||||
| 46 | (T) cMyc | NEOGENOMICS | (T) cMyc | See SOW | 5 | $ - 0 | |||||
| 47 | (T) Congo Red | NEOGENOMICS | (T) Congo Red | See SOW | 3 | $ - 0 | |||||
| 48 | (T) CXCL13 | NEOGENOMICS | (T) CXCL13 | See SOW | 4 | $ - 0 | |||||
| 49 | (T) Desmin | NEOGENOMICS | (T) Desmin | See SOW | 2 | $ - 0 | |||||
| 50 | (T) DOG1 | NEOGENOMICS | (T) DOG1 | See SOW | 3 | $ - 0 | |||||
| 51 | (T) E-Cadherin | NEOGENOMICS | (T) E-Cadherin | See SOW | 6 | $ - 0 | |||||
| 52 | (T) EBER ISH | NEOGENOMICS | (T) EBER ISH | See SOW | 26 | $ - 0 | |||||
| 53 | (T) EBV (LMP1) | NEOGENOMICS | (T) EBV (LMP1) | See SOW | 2 | $ - 0 | |||||
| 54 | (T) Elastic Stain | NEOGENOMICS | (T) Elastic Stain | See SOW | 3 | $ - 0 | |||||
| 55 | (T) ER | NEOGENOMICS | (T) ER | See SOW | 3 | $ - 0 | |||||
| 56 | (T) ER Qualitative | NEOGENOMICS | (T) ER Qualitative | See SOW | 8 | $ - 0 | |||||
| 57 | (T) ERG | NEOGENOMICS | (T) ERG | See SOW | 7 | $ - 0 | |||||
| 58 | (T) Factor XIIIa | NEOGENOMICS | (T) Factor XIIIa | See SOW | 2 | $ - 0 | |||||
| 59 | (T) Fli-1 | NEOGENOMICS | (T) Fli-1 | See SOW | 2 | $ - 0 | |||||
| 60 | (T) Gastrin | NEOGENOMICS | (T) Gastrin | See SOW | 5 | $ - 0 | |||||
| 61 | (T) GCDFP15 | NEOGENOMICS | (T) GCDFP15 | See SOW | 2 | $ - 0 | |||||
| 62 | (T) Glypican-3 | NEOGENOMICS | (T) Glypican-3 | See SOW | 12 | $ - 0 | |||||
| 63 | (T) GMS | NEOGENOMICS | (T) GMS | See SOW | 12 | $ - 0 | |||||
| 64 | (T) Gram Stain | NEOGENOMICS | (T) Gram Stain | See SOW | 8 | $ - 0 | |||||
| 65 | (T) Granzyme B | NEOGENOMICS | (T) Granzyme B | See SOW | 4 | $ - 0 | |||||
| 66 | (T) H3K27me3 | NEOGENOMICS | (T) H3K27me3 | See SOW | 2 | $ - 0 | |||||
| 67 | (T) H. Pylori | NEOGENOMICS | (T) H. Pylori | See SOW | 7 | $ - 0 | |||||
| 68 | (T) HCG Beta | NEOGENOMICS | (T) HCG Beta | See SOW | 2 | $ - 0 | |||||
| 69 | (T) HER2 (Other) – with Breast Scoring | NEOGENOMICS | (T) HER2 (Other) – with Breast Scoring | See SOW | 7 | $ - 0 | |||||
| 70 | (T) HER2 (Other) – with Gastric Scoring | NEOGENOMICS | (T) HER2 (Other) – with Gastric Scoring | See SOW | 2 | $ - 0 | |||||
| 71 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 5 | $ - 0 | |||||
| 72 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 10 | $ - 0 | |||||
| 73 | (T) HHV8 | NEOGENOMICS | (T) HHV8 | See SOW | 11 | $ - 0 | |||||
| 74 | (T) Histology Other | NEOGENOMICS | (T) Histology Other | See SOW | 5 | $ - 0 | |||||
| 75 | (T) HMB45 | NEOGENOMICS | (T) HMB45 | See SOW | 2 | $ - 0 | |||||
| 76 | (T) HPV RNA ISH High Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH High Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 77 | (T) HPV RNA ISH Low Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH Low Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 78 | (T) HSV1/2 | NEOGENOMICS | (T) HSV1/2 | See SOW | 11 | $ - 0 | |||||
| 79 | (T) ICOS | NEOGENOMICS | (T) ICOS | See SOW | 3 | $ - 0 | |||||
| 80 | (T) Ig G | NEOGENOMICS | (T) Ig G | See SOW | 11 | $ - 0 | |||||
| 81 | (T) IgG4 | NEOGENOMICS | (T) IgG4 | See SOW | 11 | $ - 0 | |||||
| 82 | (T) Inhibin | NEOGENOMICS | (T) Inhibin | See SOW | 2 | $ - 0 | |||||
| 83 | (T) INI1 | NEOGENOMICS | (T) INI1 | See SOW | 2 | $ - 0 | |||||
| 84 | (T) INSM1 | NEOGENOMICS | (T) INSM1 | See SOW | 4 | $ - 0 | |||||
| 85 | (T) Ki67 | NEOGENOMICS | (T) Ki67 | See SOW | 3 | $ - 0 | |||||
| 86 | (T) Langerin | NEOGENOMICS | (T) Langerin | See SOW | 2 | $ - 0 | |||||
| 87 | (T) LEF1 | NEOGENOMICS | (T) LEF1 | See SOW | 2 | $ - 0 | |||||
| 88 | (T) LMO2 | NEOGENOMICS | (T) LMO2 | See SOW | 2 | $ - 0 | |||||
| 89 | (T) Mammaglobin | NEOGENOMICS | (T) Mammaglobin | See SOW | 5 | $ - 0 | |||||
| 90 | (T) MPO | NEOGENOMICS | (T) MPO | See SOW | 4 | $ - 0 | |||||
| 91 | (T) MSH2 Qualitative | NEOGENOMICS | (T) MSH2 Qualitative | See SOW | 3 | $ - 0 | |||||
| 92 | (T) MUC1 | NEOGENOMICS | (T) MUC1 | See SOW | 2 | $ - 0 | |||||
| 93 | (T) MUC2 | NEOGENOMICS | (T) MUC2 | See SOW | 2 | $ - 0 | |||||
| 94 | (T) MUC5 | NEOGENOMICS | (T) MUC5 | See SOW | 2 | $ - 0 | |||||
| 95 | (T) MUC6 | NEOGENOMICS | (T) MUC6 | See SOW | 2 | $ - 0 | |||||
| 96 | (T) MUM1 | NEOGENOMICS | (T) MUM1 | See SOW | 19 | $ - 0 | |||||
| 97 | (T) NF (Neurofilament) | NEOGENOMICS | (T) NF (Neurofilament) | See SOW | 2 | $ - 0 | |||||
| 98 | (T) NKX2.2 | NEOGENOMICS | (T) NKX2.2 | See SOW | 2 | $ - 0 | |||||
| 99 | (T) NKX3.1 | NEOGENOMICS | (T) NKX3.1 | See SOW | 3 | $ - 0 | |||||
| 100 | (T) OCT2 | NEOGENOMICS | (T) OCT2 | See SOW | 3 | $ - 0 | |||||
| 101 | (T) OCT4 | NEOGENOMICS | (T) OCT4 | See SOW | 4 | $ - 0 | |||||
| 102 | (T) p40 | NEOGENOMICS | (T) p40 | See SOW | 2 | $ - 0 | |||||
| 103 | (T) P63 | NEOGENOMICS | (T) P63 | See SOW | 2 | $ - 0 | |||||
| 104 | (T) P504S | NEOGENOMICS | (T) P504S | See SOW | 2 | $ - 0 | |||||
| 105 | (T) Pan-Cytokeratin | NEOGENOMICS | (T) Pan-Cytokeratin | See SOW | 7 | $ - 0 | |||||
| 106 | (T) PAS | NEOGENOMICS | (T) PAS | See SOW | 2 | $ - 0 | |||||
| 107 | (T) PAX2 | NEOGENOMICS | (T) PAX2 | See SOW | 2 | $ - 0 | |||||
| 108 | (T) PAX5 | NEOGENOMICS | (T) PAX5 | See SOW | 5 | $ - 0 | |||||
| 109 | (T) PD1 | NEOGENOMICS | (T) PD1 | See SOW | 6 | $ - 0 | |||||
| 110 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 111 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | See SOW | 12 | $ - 0 | |||||
| 112 | (T) PD-L1 22C3 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 22C3 FDA for NSCLC | See SOW | 66 | $ - 0 | |||||
| 113 | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | NEOGENOMICS | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | See SOW | 7 | $ - 0 | |||||
| 114 | (T) PD-L1 28-8 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 28-8 FDA for NSCLC | See SOW | 3 | $ - 0 | |||||
| 115 | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | NEOGENOMICS | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | See SOW | 2 | $ - 0 | |||||
| 116 | (T) Periodic Acid Schiff with Digestion (PASD) | NEOGENOMICS | (T) Periodic Acid Schiff with Digestion (PASD) | See SOW | 5 | $ - 0 | |||||
| 117 | (T) PgR | NEOGENOMICS | (T) PgR | See SOW | 3 | $ - 0 | |||||
| 118 | (T) PLAP | NEOGENOMICS | (T) PLAP | See SOW | 2 | $ - 0 | |||||
| 119 | (T) PMS2 | NEOGENOMICS | (T) PMS2 | See SOW | 7 | $ - 0 | |||||
| 120 | (T) PMS2 Qualitative | NEOGENOMICS | (T) PMS2 Qualitative | See SOW | 26 | $ - 0 | |||||
| 121 | (T) PSA | NEOGENOMICS | (T) PSA | See SOW | 2 | $ - 0 | |||||
| 122 | (T) PTH | NEOGENOMICS | (T) PTH | See SOW | 2 | $ - 0 | |||||
| 123 | (T) Retinoblastoma Protein (RB) | NEOGENOMICS | (T) Retinoblastoma Protein (RB) | See SOW | 3 | $ - 0 | |||||
| 124 | (T) S100 | NEOGENOMICS | (T) S100 | See SOW | 6 | $ - 0 | |||||
| 125 | (T) SATB2 | NEOGENOMICS | (T) SATB2 | See SOW | 3 | $ - 0 | |||||
| 126 | (T) SMA | NEOGENOMICS | (T) SMA | See SOW | 2 | $ - 0 | |||||
| 127 | (T) SMMHC | NEOGENOMICS | (T) SMMHC | See SOW | 2 | $ - 0 | |||||
| 128 | (T) Somatostatin Receptor, Type 2 | NEOGENOMICS | (T) Somatostatin Receptor, Type 2 | See SOW | 3 | $ - 0 | |||||
| 129 | (T) SOX10 | NEOGENOMICS | (T) SOX10 | See SOW | 2 | $ - 0 | |||||
| 130 | (T) SOX11 | NEOGENOMICS | (T) SOX11 | See SOW | 3 | $ - 0 | |||||
| 131 | (T) Spirochete | NEOGENOMICS | (T) Spirochete | See SOW | 4 | $ - 0 | |||||
| 132 | (T) STAT6 | NEOGENOMICS | (T) STAT6 | See SOW | 5 | $ - 0 | |||||
| 133 | (T) Synaptophysin | NEOGENOMICS | (T) Synaptophysin | See SOW | 2 | $ - 0 | |||||
| 134 | (T) TCL1 | NEOGENOMICS | (T) TCL1 | See SOW | 4 | $ - 0 | |||||
| 135 | (T) TdT | NEOGENOMICS | (T) TdT | See SOW | 6 | $ - 0 | |||||
| 136 | (T) TIA1 | NEOGENOMICS | (T) TIA1 | See SOW | 3 | $ - 0 | |||||
| 137 | (T) TLE1 | NEOGENOMICS | (T) TLE1 | See SOW | 2 | $ - 0 | |||||
| 138 | (T) Toxoplasma | NEOGENOMICS | (T) Toxoplasma | See SOW | 2 | $ - 0 | |||||
| 139 | (T) Trichrome | NEOGENOMICS | (T) Trichrome | See SOW | 4 | $ - 0 | |||||
| 140 | (T) Tryptase | NEOGENOMICS | (T) Tryptase | See SOW | 4 | $ - 0 | |||||
| 141 | (T) TTF1 | NEOGENOMICS | (T) TTF1 | See SOW | 6 | $ - 0 | |||||
| 142 | (T) Uroplakin II | NEOGENOMICS | (T) Uroplakin II | See SOW | 2 | $ - 0 | |||||
| 143 | (T) Uroplakin III | NEOGENOMICS | (T) Uroplakin III | See SOW | 2 | $ - 0 | |||||
| 144 | (T) Villin | NEOGENOMICS | (T) Villin | See SOW | 2 | $ - 0 | |||||
| 145 | (T) WT1 | NEOGENOMICS | (T) WT1 | See SOW | 8 | $ - 0 | |||||
| 146 | (P) NeoTYPE® ALL Profile (Molecular Only) | NEOGENOMICS | (P) NeoTYPE® ALL Profile (Molecular Only) | See SOW | 2 | $ - 0 | |||||
| 147 | (P) Sarcoma Comprehensive NGS Fusion Panel | NEOGENOMICS | (P) Sarcoma Comprehensive NGS Fusion Panel | See SOW | 2 | $ - 0 | |||||
| 148 | (T) B-Cell Gene Rearrangement | NEOGENOMICS | (T) B-Cell Gene Rearrangement | See SOW | 3 | $ - 0 | |||||
| 149 | (T) CXCR4 Mutation Analysis | NEOGENOMICS | (T) CXCR4 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 150 | (T) MLH1 Promoter Methylation Analysis | NEOGENOMICS | (T) MLH1 Promoter Methylation Analysis | See SOW | 2 | $ - 0 | |||||
| 151 | (T) MYD88 Mutation Analysis | NEOGENOMICS | (T) MYD88 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 152 | (T) T-Cell Receptor Beta Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Beta Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 153 | (T) T-Cell Receptor Gamma Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Gamma Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 154 | Calcium stain | NEOGENOMICS | Calcium stain | See SOW | 11 | $ - 0 | |||||
| 155 | MLH1 Qualitative | NEOGENOMICS | MLH1 Qualitative | See SOW | 3 | $ - 0 | |||||
| 156 | MSH6 Qualitative | NEOGENOMICS | MSH6 Qualitative | See SOW | 3 | $ - 0 | |||||
| 157 | Periodic Acid Schiff for Fungus (PASF) | NEOGENOMICS | Periodic Acid Schiff for Fungus (PASF) | See SOW | 12 | $ - 0 | |||||
| $ - 0 | |||||||||||
| Total | $ - 0 |
2. Option 1
| CLIN | Brand Name | Brand Name Nomenclature | Manufacturer Part Number | Salient Characteristics | Equivalent Brand | Equivalent Nomenclature | Equivalent Part Number | Equivalent Description Matching Salient Characteristics and/or location of information regarding equal capability | Quantity | Unit Price | Extended Price |
| 1 | (T) DDIT3 (CHOP)(12q13) | NEOGENOMICS | (T) DDIT3 (CHOP)(12q13) | See SOW | 2 | $ - 0 | |||||
| 2 | (T) H&E | NEOGENOMICS | (T) H&E | See SOW | 11 | $ - 0 | |||||
| 3 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 3 | $ - 0 | |||||
| 4 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 5 | (T) MDM2 | NEOGENOMICS | (T) MDM2 | See SOW | 8 | $ - 0 | |||||
| 6 | (P) AML MRD Flow Panel | NEOGENOMICS | (P) AML MRD Flow Panel | See SOW | 2 | $ - 0 | |||||
| 7 | (P) Amyloid A & P | NEOGENOMICS | (P) Amyloid A & P | See SOW | 3 | $ - 0 | |||||
| 8 | (P) Breast Panel (2 Stain) | NEOGENOMICS | (P) Breast Panel (2 Stain) | See SOW | 4 | $ - 0 | |||||
| 9 | (P) Breast Panel (3 Stain) | NEOGENOMICS | (P) Breast Panel (3 Stain) | See SOW | 4 | $ - 0 | |||||
| 10 | (P) Breast Panel (4 Stain) | NEOGENOMICS | (P) Breast Panel (4 Stain) | See SOW | 2 | $ - 0 | |||||
| 11 | (P) HPV RNA ISH Panel | NEOGENOMICS | (P) HPV RNA ISH Panel | See SOW | 8 | $ - 0 | |||||
| 12 | (P) Mismatch Repair (MMR) IHC Panel Qualitative | NEOGENOMICS | (P) Mismatch Repair (MMR) IHC Panel Qualitative | See SOW | 3 | $ - 0 | |||||
| 13 | (T) AFP | NEOGENOMICS | (T) AFP | See SOW | 4 | $ - 0 | |||||
| 14 | (T) Albumin RNA ISH | NEOGENOMICS | (T) Albumin RNA ISH | See SOW | 3 | $ - 0 | |||||
| 15 | (T) ALK (D5F3) | NEOGENOMICS | (T) ALK (D5F3) | See SOW | 4 | $ - 0 | |||||
| 16 | (T) ALK-1 (for Heme cases) | NEOGENOMICS | (T) ALK-1 (for Heme cases) | See SOW | 17 | $ - 0 | |||||
| 17 | (T) AR | NEOGENOMICS | (T) AR | See SOW | 2 | $ - 0 | |||||
| 18 | (T) AR Qualitative | NEOGENOMICS | (T) AR Qualitative | See SOW | 2 | $ - 0 | |||||
| 19 | (T) Arginase 1 | NEOGENOMICS | (T) Arginase 1 | See SOW | 12 | $ - 0 | |||||
| 20 | (T) BOB1 | NEOGENOMICS | (T) BOB1 | See SOW | 2 | $ - 0 | |||||
| 21 | (T) CA19.9 | NEOGENOMICS | (T) CA19.9 | See SOW | 2 | $ - 0 | |||||
| 22 | (T) Calcitonin | NEOGENOMICS | (T) Calcitonin | See SOW | 2 | $ - 0 | |||||
| 23 | (T) Calponin | NEOGENOMICS | (T) Calponin | See SOW | 2 | $ - 0 | |||||
| 24 | (T) Calretinin | NEOGENOMICS | (T) Calretinin | See SOW | 2 | $ - 0 | |||||
| 25 | (T) CD1a | NEOGENOMICS | (T) CD1a | See SOW | 3 | $ - 0 | |||||
| 26 | (T) CD2 | NEOGENOMICS | (T) CD2 | See SOW | 2 | $ - 0 | |||||
| 27 | (T) CD14 | NEOGENOMICS | (T) CD14 | See SOW | 2 | $ - 0 | |||||
| 28 | (T) CD15 | NEOGENOMICS | (T) CD15 | See SOW | 2 | $ - 0 | |||||
| 29 | (T) CD23 | NEOGENOMICS | (T) CD23 | See SOW | 4 | $ - 0 | |||||
| 30 | (T) CD25 | NEOGENOMICS | (T) CD25 | See SOW | 4 | $ - 0 | |||||
| 31 | (T) CD33 | NEOGENOMICS | (T) CD33 | See SOW | 2 | $ - 0 | |||||
| 32 | (T) CD42b | NEOGENOMICS | (T) CD42b | See SOW | 4 | $ - 0 | |||||
| 33 | (T) CD44 | NEOGENOMICS | (T) CD44 | See SOW | 5 | $ - 0 | |||||
| 34 | (T) CD61 | NEOGENOMICS | (T) CD61 | See SOW | 9 | $ - 0 | |||||
| 35 | (T) CD71 | NEOGENOMICS | (T) CD71 | See SOW | 4 | $ - 0 | |||||
| 36 | (T) CD79a | NEOGENOMICS | (T) CD79a | See SOW | 7 | $ - 0 | |||||
| 37 | (T) CD117 cKIT | NEOGENOMICS | (T) CD117 cKIT | See SOW | 3 | $ - 0 | |||||
| 38 | (T) CD123 | NEOGENOMICS | (T) CD123 | See SOW | 8 | $ - 0 | |||||
| 39 | (T) CD163 | NEOGENOMICS | (T) CD163 | See SOW | 3 | $ - 0 | |||||
| 40 | (T) CEA (Poly) | NEOGENOMICS | (T) CEA (Poly) | See SOW | 3 | $ - 0 | |||||
| 41 | (T) CK 7 | NEOGENOMICS | (T) CK 7 | See SOW | 7 | $ - 0 | |||||
| 42 | (T) CK 19 | NEOGENOMICS | (T) CK 19 | See SOW | 9 | $ - 0 | |||||
| 43 | (T) CK OSCAR | NEOGENOMICS | (T) CK OSCAR | See SOW | 7 | $ - 0 | |||||
| 44 | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | NEOGENOMICS | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | See SOW | 3 | $ - 0 | |||||
| 45 | (T) CMV by IHC | NEOGENOMICS | (T) CMV by IHC | See SOW | 28 | $ - 0 | |||||
| 46 | (T) cMyc | NEOGENOMICS | (T) cMyc | See SOW | 5 | $ - 0 | |||||
| 47 | (T) Congo Red | NEOGENOMICS | (T) Congo Red | See SOW | 3 | $ - 0 | |||||
| 48 | (T) CXCL13 | NEOGENOMICS | (T) CXCL13 | See SOW | 4 | $ - 0 | |||||
| 49 | (T) Desmin | NEOGENOMICS | (T) Desmin | See SOW | 2 | $ - 0 | |||||
| 50 | (T) DOG1 | NEOGENOMICS | (T) DOG1 | See SOW | 3 | $ - 0 | |||||
| 51 | (T) E-Cadherin | NEOGENOMICS | (T) E-Cadherin | See SOW | 6 | $ - 0 | |||||
| 52 | (T) EBER ISH | NEOGENOMICS | (T) EBER ISH | See SOW | 26 | $ - 0 | |||||
| 53 | (T) EBV (LMP1) | NEOGENOMICS | (T) EBV (LMP1) | See SOW | 2 | $ - 0 | |||||
| 54 | (T) Elastic Stain | NEOGENOMICS | (T) Elastic Stain | See SOW | 3 | $ - 0 | |||||
| 55 | (T) ER | NEOGENOMICS | (T) ER | See SOW | 3 | $ - 0 | |||||
| 56 | (T) ER Qualitative | NEOGENOMICS | (T) ER Qualitative | See SOW | 8 | $ - 0 | |||||
| 57 | (T) ERG | NEOGENOMICS | (T) ERG | See SOW | 7 | $ - 0 | |||||
| 58 | (T) Factor XIIIa | NEOGENOMICS | (T) Factor XIIIa | See SOW | 2 | $ - 0 | |||||
| 59 | (T) Fli-1 | NEOGENOMICS | (T) Fli-1 | See SOW | 2 | $ - 0 | |||||
| 60 | (T) Gastrin | NEOGENOMICS | (T) Gastrin | See SOW | 5 | $ - 0 | |||||
| 61 | (T) GCDFP15 | NEOGENOMICS | (T) GCDFP15 | See SOW | 2 | $ - 0 | |||||
| 62 | (T) Glypican-3 | NEOGENOMICS | (T) Glypican-3 | See SOW | 12 | $ - 0 | |||||
| 63 | (T) GMS | NEOGENOMICS | (T) GMS | See SOW | 12 | $ - 0 | |||||
| 64 | (T) Gram Stain | NEOGENOMICS | (T) Gram Stain | See SOW | 8 | $ - 0 | |||||
| 65 | (T) Granzyme B | NEOGENOMICS | (T) Granzyme B | See SOW | 4 | $ - 0 | |||||
| 66 | (T) H3K27me3 | NEOGENOMICS | (T) H3K27me3 | See SOW | 2 | $ - 0 | |||||
| 67 | (T) H. Pylori | NEOGENOMICS | (T) H. Pylori | See SOW | 7 | $ - 0 | |||||
| 68 | (T) HCG Beta | NEOGENOMICS | (T) HCG Beta | See SOW | 2 | $ - 0 | |||||
| 69 | (T) HER2 (Other) – with Breast Scoring | NEOGENOMICS | (T) HER2 (Other) – with Breast Scoring | See SOW | 7 | $ - 0 | |||||
| 70 | (T) HER2 (Other) – with Gastric Scoring | NEOGENOMICS | (T) HER2 (Other) – with Gastric Scoring | See SOW | 2 | $ - 0 | |||||
| 71 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 5 | $ - 0 | |||||
| 72 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 10 | $ - 0 | |||||
| 73 | (T) HHV8 | NEOGENOMICS | (T) HHV8 | See SOW | 11 | $ - 0 | |||||
| 74 | (T) Histology Other | NEOGENOMICS | (T) Histology Other | See SOW | 5 | $ - 0 | |||||
| 75 | (T) HMB45 | NEOGENOMICS | (T) HMB45 | See SOW | 2 | $ - 0 | |||||
| 76 | (T) HPV RNA ISH High Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH High Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 77 | (T) HPV RNA ISH Low Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH Low Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 78 | (T) HSV1/2 | NEOGENOMICS | (T) HSV1/2 | See SOW | 11 | $ - 0 | |||||
| 79 | (T) ICOS | NEOGENOMICS | (T) ICOS | See SOW | 3 | $ - 0 | |||||
| 80 | (T) Ig G | NEOGENOMICS | (T) Ig G | See SOW | 11 | $ - 0 | |||||
| 81 | (T) IgG4 | NEOGENOMICS | (T) IgG4 | See SOW | 11 | $ - 0 | |||||
| 82 | (T) Inhibin | NEOGENOMICS | (T) Inhibin | See SOW | 2 | $ - 0 | |||||
| 83 | (T) INI1 | NEOGENOMICS | (T) INI1 | See SOW | 2 | $ - 0 | |||||
| 84 | (T) INSM1 | NEOGENOMICS | (T) INSM1 | See SOW | 4 | $ - 0 | |||||
| 85 | (T) Ki67 | NEOGENOMICS | (T) Ki67 | See SOW | 3 | $ - 0 | |||||
| 86 | (T) Langerin | NEOGENOMICS | (T) Langerin | See SOW | 2 | $ - 0 | |||||
| 87 | (T) LEF1 | NEOGENOMICS | (T) LEF1 | See SOW | 2 | $ - 0 | |||||
| 88 | (T) LMO2 | NEOGENOMICS | (T) LMO2 | See SOW | 2 | $ - 0 | |||||
| 89 | (T) Mammaglobin | NEOGENOMICS | (T) Mammaglobin | See SOW | 5 | $ - 0 | |||||
| 90 | (T) MPO | NEOGENOMICS | (T) MPO | See SOW | 4 | $ - 0 | |||||
| 91 | (T) MSH2 Qualitative | NEOGENOMICS | (T) MSH2 Qualitative | See SOW | 3 | $ - 0 | |||||
| 92 | (T) MUC1 | NEOGENOMICS | (T) MUC1 | See SOW | 2 | $ - 0 | |||||
| 93 | (T) MUC2 | NEOGENOMICS | (T) MUC2 | See SOW | 2 | $ - 0 | |||||
| 94 | (T) MUC5 | NEOGENOMICS | (T) MUC5 | See SOW | 2 | $ - 0 | |||||
| 95 | (T) MUC6 | NEOGENOMICS | (T) MUC6 | See SOW | 2 | $ - 0 | |||||
| 96 | (T) MUM1 | NEOGENOMICS | (T) MUM1 | See SOW | 19 | $ - 0 | |||||
| 97 | (T) NF (Neurofilament) | NEOGENOMICS | (T) NF (Neurofilament) | See SOW | 2 | $ - 0 | |||||
| 98 | (T) NKX2.2 | NEOGENOMICS | (T) NKX2.2 | See SOW | 2 | $ - 0 | |||||
| 99 | (T) NKX3.1 | NEOGENOMICS | (T) NKX3.1 | See SOW | 3 | $ - 0 | |||||
| 100 | (T) OCT2 | NEOGENOMICS | (T) OCT2 | See SOW | 3 | $ - 0 | |||||
| 101 | (T) OCT4 | NEOGENOMICS | (T) OCT4 | See SOW | 4 | $ - 0 | |||||
| 102 | (T) p40 | NEOGENOMICS | (T) p40 | See SOW | 2 | $ - 0 | |||||
| 103 | (T) P63 | NEOGENOMICS | (T) P63 | See SOW | 2 | $ - 0 | |||||
| 104 | (T) P504S | NEOGENOMICS | (T) P504S | See SOW | 2 | $ - 0 | |||||
| 105 | (T) Pan-Cytokeratin | NEOGENOMICS | (T) Pan-Cytokeratin | See SOW | 7 | $ - 0 | |||||
| 106 | (T) PAS | NEOGENOMICS | (T) PAS | See SOW | 2 | $ - 0 | |||||
| 107 | (T) PAX2 | NEOGENOMICS | (T) PAX2 | See SOW | 2 | $ - 0 | |||||
| 108 | (T) PAX5 | NEOGENOMICS | (T) PAX5 | See SOW | 5 | $ - 0 | |||||
| 109 | (T) PD1 | NEOGENOMICS | (T) PD1 | See SOW | 6 | $ - 0 | |||||
| 110 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 111 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | See SOW | 12 | $ - 0 | |||||
| 112 | (T) PD-L1 22C3 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 22C3 FDA for NSCLC | See SOW | 66 | $ - 0 | |||||
| 113 | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | NEOGENOMICS | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | See SOW | 7 | $ - 0 | |||||
| 114 | (T) PD-L1 28-8 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 28-8 FDA for NSCLC | See SOW | 3 | $ - 0 | |||||
| 115 | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | NEOGENOMICS | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | See SOW | 2 | $ - 0 | |||||
| 116 | (T) Periodic Acid Schiff with Digestion (PASD) | NEOGENOMICS | (T) Periodic Acid Schiff with Digestion (PASD) | See SOW | 5 | $ - 0 | |||||
| 117 | (T) PgR | NEOGENOMICS | (T) PgR | See SOW | 3 | $ - 0 | |||||
| 118 | (T) PLAP | NEOGENOMICS | (T) PLAP | See SOW | 2 | $ - 0 | |||||
| 119 | (T) PMS2 | NEOGENOMICS | (T) PMS2 | See SOW | 7 | $ - 0 | |||||
| 120 | (T) PMS2 Qualitative | NEOGENOMICS | (T) PMS2 Qualitative | See SOW | 26 | $ - 0 | |||||
| 121 | (T) PSA | NEOGENOMICS | (T) PSA | See SOW | 2 | $ - 0 | |||||
| 122 | (T) PTH | NEOGENOMICS | (T) PTH | See SOW | 2 | $ - 0 | |||||
| 123 | (T) Retinoblastoma Protein (RB) | NEOGENOMICS | (T) Retinoblastoma Protein (RB) | See SOW | 3 | $ - 0 | |||||
| 124 | (T) S100 | NEOGENOMICS | (T) S100 | See SOW | 6 | $ - 0 | |||||
| 125 | (T) SATB2 | NEOGENOMICS | (T) SATB2 | See SOW | 3 | $ - 0 | |||||
| 126 | (T) SMA | NEOGENOMICS | (T) SMA | See SOW | 2 | $ - 0 | |||||
| 127 | (T) SMMHC | NEOGENOMICS | (T) SMMHC | See SOW | 2 | $ - 0 | |||||
| 128 | (T) Somatostatin Receptor, Type 2 | NEOGENOMICS | (T) Somatostatin Receptor, Type 2 | See SOW | 3 | $ - 0 | |||||
| 129 | (T) SOX10 | NEOGENOMICS | (T) SOX10 | See SOW | 2 | $ - 0 | |||||
| 130 | (T) SOX11 | NEOGENOMICS | (T) SOX11 | See SOW | 3 | $ - 0 | |||||
| 131 | (T) Spirochete | NEOGENOMICS | (T) Spirochete | See SOW | 4 | $ - 0 | |||||
| 132 | (T) STAT6 | NEOGENOMICS | (T) STAT6 | See SOW | 5 | $ - 0 | |||||
| 133 | (T) Synaptophysin | NEOGENOMICS | (T) Synaptophysin | See SOW | 2 | $ - 0 | |||||
| 134 | (T) TCL1 | NEOGENOMICS | (T) TCL1 | See SOW | 4 | $ - 0 | |||||
| 135 | (T) TdT | NEOGENOMICS | (T) TdT | See SOW | 6 | $ - 0 | |||||
| 136 | (T) TIA1 | NEOGENOMICS | (T) TIA1 | See SOW | 3 | $ - 0 | |||||
| 137 | (T) TLE1 | NEOGENOMICS | (T) TLE1 | See SOW | 2 | $ - 0 | |||||
| 138 | (T) Toxoplasma | NEOGENOMICS | (T) Toxoplasma | See SOW | 2 | $ - 0 | |||||
| 139 | (T) Trichrome | NEOGENOMICS | (T) Trichrome | See SOW | 4 | $ - 0 | |||||
| 140 | (T) Tryptase | NEOGENOMICS | (T) Tryptase | See SOW | 4 | $ - 0 | |||||
| 141 | (T) TTF1 | NEOGENOMICS | (T) TTF1 | See SOW | 6 | $ - 0 | |||||
| 142 | (T) Uroplakin II | NEOGENOMICS | (T) Uroplakin II | See SOW | 2 | $ - 0 | |||||
| 143 | (T) Uroplakin III | NEOGENOMICS | (T) Uroplakin III | See SOW | 2 | $ - 0 | |||||
| 144 | (T) Villin | NEOGENOMICS | (T) Villin | See SOW | 2 | $ - 0 | |||||
| 145 | (T) WT1 | NEOGENOMICS | (T) WT1 | See SOW | 8 | $ - 0 | |||||
| 146 | (P) NeoTYPE® ALL Profile (Molecular Only) | NEOGENOMICS | (P) NeoTYPE® ALL Profile (Molecular Only) | See SOW | 2 | $ - 0 | |||||
| 147 | (P) Sarcoma Comprehensive NGS Fusion Panel | NEOGENOMICS | (P) Sarcoma Comprehensive NGS Fusion Panel | See SOW | 2 | $ - 0 | |||||
| 148 | (T) B-Cell Gene Rearrangement | NEOGENOMICS | (T) B-Cell Gene Rearrangement | See SOW | 3 | $ - 0 | |||||
| 149 | (T) CXCR4 Mutation Analysis | NEOGENOMICS | (T) CXCR4 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 150 | (T) MLH1 Promoter Methylation Analysis | NEOGENOMICS | (T) MLH1 Promoter Methylation Analysis | See SOW | 2 | $ - 0 | |||||
| 151 | (T) MYD88 Mutation Analysis | NEOGENOMICS | (T) MYD88 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 152 | (T) T-Cell Receptor Beta Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Beta Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 153 | (T) T-Cell Receptor Gamma Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Gamma Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 154 | Calcium stain | NEOGENOMICS | Calcium stain | See SOW | 11 | $ - 0 | |||||
| 155 | MLH1 Qualitative | NEOGENOMICS | MLH1 Qualitative | See SOW | 3 | $ - 0 | |||||
| 156 | MSH6 Qualitative | NEOGENOMICS | MSH6 Qualitative | See SOW | 3 | $ - 0 | |||||
| 157 | Periodic Acid Schiff for Fungus (PASF) | NEOGENOMICS | Periodic Acid Schiff for Fungus (PASF) | See SOW | 12 | $ - 0 | |||||
| $ - 0 | |||||||||||
| Total | $ - 0 |
3. Option 2
| CLIN | Brand Name | Brand Name Nomenclature | Manufacturer Part Number | Salient Characteristics | Equivalent Brand | Equivalent Nomenclature | Equivalent Part Number | Equivalent Description Matching Salient Characteristics and/or location of information regarding equal capability | Quantity | Unit Price | Extended Price |
| 1 | (T) DDIT3 (CHOP)(12q13) | NEOGENOMICS | (T) DDIT3 (CHOP)(12q13) | See SOW | 2 | $ - 0 | |||||
| 2 | (T) H&E | NEOGENOMICS | (T) H&E | See SOW | 11 | $ - 0 | |||||
| 3 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 3 | $ - 0 | |||||
| 4 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 5 | (T) MDM2 | NEOGENOMICS | (T) MDM2 | See SOW | 8 | $ - 0 | |||||
| 6 | (P) AML MRD Flow Panel | NEOGENOMICS | (P) AML MRD Flow Panel | See SOW | 2 | $ - 0 | |||||
| 7 | (P) Amyloid A & P | NEOGENOMICS | (P) Amyloid A & P | See SOW | 3 | $ - 0 | |||||
| 8 | (P) Breast Panel (2 Stain) | NEOGENOMICS | (P) Breast Panel (2 Stain) | See SOW | 4 | $ - 0 | |||||
| 9 | (P) Breast Panel (3 Stain) | NEOGENOMICS | (P) Breast Panel (3 Stain) | See SOW | 4 | $ - 0 | |||||
| 10 | (P) Breast Panel (4 Stain) | NEOGENOMICS | (P) Breast Panel (4 Stain) | See SOW | 2 | $ - 0 | |||||
| 11 | (P) HPV RNA ISH Panel | NEOGENOMICS | (P) HPV RNA ISH Panel | See SOW | 8 | $ - 0 | |||||
| 12 | (P) Mismatch Repair (MMR) IHC Panel Qualitative | NEOGENOMICS | (P) Mismatch Repair (MMR) IHC Panel Qualitative | See SOW | 3 | $ - 0 | |||||
| 13 | (T) AFP | NEOGENOMICS | (T) AFP | See SOW | 4 | $ - 0 | |||||
| 14 | (T) Albumin RNA ISH | NEOGENOMICS | (T) Albumin RNA ISH | See SOW | 3 | $ - 0 | |||||
| 15 | (T) ALK (D5F3) | NEOGENOMICS | (T) ALK (D5F3) | See SOW | 4 | $ - 0 | |||||
| 16 | (T) ALK-1 (for Heme cases) | NEOGENOMICS | (T) ALK-1 (for Heme cases) | See SOW | 17 | $ - 0 | |||||
| 17 | (T) AR | NEOGENOMICS | (T) AR | See SOW | 2 | $ - 0 | |||||
| 18 | (T) AR Qualitative | NEOGENOMICS | (T) AR Qualitative | See SOW | 2 | $ - 0 | |||||
| 19 | (T) Arginase 1 | NEOGENOMICS | (T) Arginase 1 | See SOW | 12 | $ - 0 | |||||
| 20 | (T) BOB1 | NEOGENOMICS | (T) BOB1 | See SOW | 2 | $ - 0 | |||||
| 21 | (T) CA19.9 | NEOGENOMICS | (T) CA19.9 | See SOW | 2 | $ - 0 | |||||
| 22 | (T) Calcitonin | NEOGENOMICS | (T) Calcitonin | See SOW | 2 | $ - 0 | |||||
| 23 | (T) Calponin | NEOGENOMICS | (T) Calponin | See SOW | 2 | $ - 0 | |||||
| 24 | (T) Calretinin | NEOGENOMICS | (T) Calretinin | See SOW | 2 | $ - 0 | |||||
| 25 | (T) CD1a | NEOGENOMICS | (T) CD1a | See SOW | 3 | $ - 0 | |||||
| 26 | (T) CD2 | NEOGENOMICS | (T) CD2 | See SOW | 2 | $ - 0 | |||||
| 27 | (T) CD14 | NEOGENOMICS | (T) CD14 | See SOW | 2 | $ - 0 | |||||
| 28 | (T) CD15 | NEOGENOMICS | (T) CD15 | See SOW | 2 | $ - 0 | |||||
| 29 | (T) CD23 | NEOGENOMICS | (T) CD23 | See SOW | 4 | $ - 0 | |||||
| 30 | (T) CD25 | NEOGENOMICS | (T) CD25 | See SOW | 4 | $ - 0 | |||||
| 31 | (T) CD33 | NEOGENOMICS | (T) CD33 | See SOW | 2 | $ - 0 | |||||
| 32 | (T) CD42b | NEOGENOMICS | (T) CD42b | See SOW | 4 | $ - 0 | |||||
| 33 | (T) CD44 | NEOGENOMICS | (T) CD44 | See SOW | 5 | $ - 0 | |||||
| 34 | (T) CD61 | NEOGENOMICS | (T) CD61 | See SOW | 9 | $ - 0 | |||||
| 35 | (T) CD71 | NEOGENOMICS | (T) CD71 | See SOW | 4 | $ - 0 | |||||
| 36 | (T) CD79a | NEOGENOMICS | (T) CD79a | See SOW | 7 | $ - 0 | |||||
| 37 | (T) CD117 cKIT | NEOGENOMICS | (T) CD117 cKIT | See SOW | 3 | $ - 0 | |||||
| 38 | (T) CD123 | NEOGENOMICS | (T) CD123 | See SOW | 8 | $ - 0 | |||||
| 39 | (T) CD163 | NEOGENOMICS | (T) CD163 | See SOW | 3 | $ - 0 | |||||
| 40 | (T) CEA (Poly) | NEOGENOMICS | (T) CEA (Poly) | See SOW | 3 | $ - 0 | |||||
| 41 | (T) CK 7 | NEOGENOMICS | (T) CK 7 | See SOW | 7 | $ - 0 | |||||
| 42 | (T) CK 19 | NEOGENOMICS | (T) CK 19 | See SOW | 9 | $ - 0 | |||||
| 43 | (T) CK OSCAR | NEOGENOMICS | (T) CK OSCAR | See SOW | 7 | $ - 0 | |||||
| 44 | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | NEOGENOMICS | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | See SOW | 3 | $ - 0 | |||||
| 45 | (T) CMV by IHC | NEOGENOMICS | (T) CMV by IHC | See SOW | 28 | $ - 0 | |||||
| 46 | (T) cMyc | NEOGENOMICS | (T) cMyc | See SOW | 5 | $ - 0 | |||||
| 47 | (T) Congo Red | NEOGENOMICS | (T) Congo Red | See SOW | 3 | $ - 0 | |||||
| 48 | (T) CXCL13 | NEOGENOMICS | (T) CXCL13 | See SOW | 4 | $ - 0 | |||||
| 49 | (T) Desmin | NEOGENOMICS | (T) Desmin | See SOW | 2 | $ - 0 | |||||
| 50 | (T) DOG1 | NEOGENOMICS | (T) DOG1 | See SOW | 3 | $ - 0 | |||||
| 51 | (T) E-Cadherin | NEOGENOMICS | (T) E-Cadherin | See SOW | 6 | $ - 0 | |||||
| 52 | (T) EBER ISH | NEOGENOMICS | (T) EBER ISH | See SOW | 26 | $ - 0 | |||||
| 53 | (T) EBV (LMP1) | NEOGENOMICS | (T) EBV (LMP1) | See SOW | 2 | $ - 0 | |||||
| 54 | (T) Elastic Stain | NEOGENOMICS | (T) Elastic Stain | See SOW | 3 | $ - 0 | |||||
| 55 | (T) ER | NEOGENOMICS | (T) ER | See SOW | 3 | $ - 0 | |||||
| 56 | (T) ER Qualitative | NEOGENOMICS | (T) ER Qualitative | See SOW | 8 | $ - 0 | |||||
| 57 | (T) ERG | NEOGENOMICS | (T) ERG | See SOW | 7 | $ - 0 | |||||
| 58 | (T) Factor XIIIa | NEOGENOMICS | (T) Factor XIIIa | See SOW | 2 | $ - 0 | |||||
| 59 | (T) Fli-1 | NEOGENOMICS | (T) Fli-1 | See SOW | 2 | $ - 0 | |||||
| 60 | (T) Gastrin | NEOGENOMICS | (T) Gastrin | See SOW | 5 | $ - 0 | |||||
| 61 | (T) GCDFP15 | NEOGENOMICS | (T) GCDFP15 | See SOW | 2 | $ - 0 | |||||
| 62 | (T) Glypican-3 | NEOGENOMICS | (T) Glypican-3 | See SOW | 12 | $ - 0 | |||||
| 63 | (T) GMS | NEOGENOMICS | (T) GMS | See SOW | 12 | $ - 0 | |||||
| 64 | (T) Gram Stain | NEOGENOMICS | (T) Gram Stain | See SOW | 8 | $ - 0 | |||||
| 65 | (T) Granzyme B | NEOGENOMICS | (T) Granzyme B | See SOW | 4 | $ - 0 | |||||
| 66 | (T) H3K27me3 | NEOGENOMICS | (T) H3K27me3 | See SOW | 2 | $ - 0 | |||||
| 67 | (T) H. Pylori | NEOGENOMICS | (T) H. Pylori | See SOW | 7 | $ - 0 | |||||
| 68 | (T) HCG Beta | NEOGENOMICS | (T) HCG Beta | See SOW | 2 | $ - 0 | |||||
| 69 | (T) HER2 (Other) – with Breast Scoring | NEOGENOMICS | (T) HER2 (Other) – with Breast Scoring | See SOW | 7 | $ - 0 | |||||
| 70 | (T) HER2 (Other) – with Gastric Scoring | NEOGENOMICS | (T) HER2 (Other) – with Gastric Scoring | See SOW | 2 | $ - 0 | |||||
| 71 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 5 | $ - 0 | |||||
| 72 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 10 | $ - 0 | |||||
| 73 | (T) HHV8 | NEOGENOMICS | (T) HHV8 | See SOW | 11 | $ - 0 | |||||
| 74 | (T) Histology Other | NEOGENOMICS | (T) Histology Other | See SOW | 5 | $ - 0 | |||||
| 75 | (T) HMB45 | NEOGENOMICS | (T) HMB45 | See SOW | 2 | $ - 0 | |||||
| 76 | (T) HPV RNA ISH High Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH High Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 77 | (T) HPV RNA ISH Low Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH Low Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 78 | (T) HSV1/2 | NEOGENOMICS | (T) HSV1/2 | See SOW | 11 | $ - 0 | |||||
| 79 | (T) ICOS | NEOGENOMICS | (T) ICOS | See SOW | 3 | $ - 0 | |||||
| 80 | (T) Ig G | NEOGENOMICS | (T) Ig G | See SOW | 11 | $ - 0 | |||||
| 81 | (T) IgG4 | NEOGENOMICS | (T) IgG4 | See SOW | 11 | $ - 0 | |||||
| 82 | (T) Inhibin | NEOGENOMICS | (T) Inhibin | See SOW | 2 | $ - 0 | |||||
| 83 | (T) INI1 | NEOGENOMICS | (T) INI1 | See SOW | 2 | $ - 0 | |||||
| 84 | (T) INSM1 | NEOGENOMICS | (T) INSM1 | See SOW | 4 | $ - 0 | |||||
| 85 | (T) Ki67 | NEOGENOMICS | (T) Ki67 | See SOW | 3 | $ - 0 | |||||
| 86 | (T) Langerin | NEOGENOMICS | (T) Langerin | See SOW | 2 | $ - 0 | |||||
| 87 | (T) LEF1 | NEOGENOMICS | (T) LEF1 | See SOW | 2 | $ - 0 | |||||
| 88 | (T) LMO2 | NEOGENOMICS | (T) LMO2 | See SOW | 2 | $ - 0 | |||||
| 89 | (T) Mammaglobin | NEOGENOMICS | (T) Mammaglobin | See SOW | 5 | $ - 0 | |||||
| 90 | (T) MPO | NEOGENOMICS | (T) MPO | See SOW | 4 | $ - 0 | |||||
| 91 | (T) MSH2 Qualitative | NEOGENOMICS | (T) MSH2 Qualitative | See SOW | 3 | $ - 0 | |||||
| 92 | (T) MUC1 | NEOGENOMICS | (T) MUC1 | See SOW | 2 | $ - 0 | |||||
| 93 | (T) MUC2 | NEOGENOMICS | (T) MUC2 | See SOW | 2 | $ - 0 | |||||
| 94 | (T) MUC5 | NEOGENOMICS | (T) MUC5 | See SOW | 2 | $ - 0 | |||||
| 95 | (T) MUC6 | NEOGENOMICS | (T) MUC6 | See SOW | 2 | $ - 0 | |||||
| 96 | (T) MUM1 | NEOGENOMICS | (T) MUM1 | See SOW | 19 | $ - 0 | |||||
| 97 | (T) NF (Neurofilament) | NEOGENOMICS | (T) NF (Neurofilament) | See SOW | 2 | $ - 0 | |||||
| 98 | (T) NKX2.2 | NEOGENOMICS | (T) NKX2.2 | See SOW | 2 | $ - 0 | |||||
| 99 | (T) NKX3.1 | NEOGENOMICS | (T) NKX3.1 | See SOW | 3 | $ - 0 | |||||
| 100 | (T) OCT2 | NEOGENOMICS | (T) OCT2 | See SOW | 3 | $ - 0 | |||||
| 101 | (T) OCT4 | NEOGENOMICS | (T) OCT4 | See SOW | 4 | $ - 0 | |||||
| 102 | (T) p40 | NEOGENOMICS | (T) p40 | See SOW | 2 | $ - 0 | |||||
| 103 | (T) P63 | NEOGENOMICS | (T) P63 | See SOW | 2 | $ - 0 | |||||
| 104 | (T) P504S | NEOGENOMICS | (T) P504S | See SOW | 2 | $ - 0 | |||||
| 105 | (T) Pan-Cytokeratin | NEOGENOMICS | (T) Pan-Cytokeratin | See SOW | 7 | $ - 0 | |||||
| 106 | (T) PAS | NEOGENOMICS | (T) PAS | See SOW | 2 | $ - 0 | |||||
| 107 | (T) PAX2 | NEOGENOMICS | (T) PAX2 | See SOW | 2 | $ - 0 | |||||
| 108 | (T) PAX5 | NEOGENOMICS | (T) PAX5 | See SOW | 5 | $ - 0 | |||||
| 109 | (T) PD1 | NEOGENOMICS | (T) PD1 | See SOW | 6 | $ - 0 | |||||
| 110 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 111 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | See SOW | 12 | $ - 0 | |||||
| 112 | (T) PD-L1 22C3 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 22C3 FDA for NSCLC | See SOW | 66 | $ - 0 | |||||
| 113 | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | NEOGENOMICS | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | See SOW | 7 | $ - 0 | |||||
| 114 | (T) PD-L1 28-8 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 28-8 FDA for NSCLC | See SOW | 3 | $ - 0 | |||||
| 115 | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | NEOGENOMICS | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | See SOW | 2 | $ - 0 | |||||
| 116 | (T) Periodic Acid Schiff with Digestion (PASD) | NEOGENOMICS | (T) Periodic Acid Schiff with Digestion (PASD) | See SOW | 5 | $ - 0 | |||||
| 117 | (T) PgR | NEOGENOMICS | (T) PgR | See SOW | 3 | $ - 0 | |||||
| 118 | (T) PLAP | NEOGENOMICS | (T) PLAP | See SOW | 2 | $ - 0 | |||||
| 119 | (T) PMS2 | NEOGENOMICS | (T) PMS2 | See SOW | 7 | $ - 0 | |||||
| 120 | (T) PMS2 Qualitative | NEOGENOMICS | (T) PMS2 Qualitative | See SOW | 26 | $ - 0 | |||||
| 121 | (T) PSA | NEOGENOMICS | (T) PSA | See SOW | 2 | $ - 0 | |||||
| 122 | (T) PTH | NEOGENOMICS | (T) PTH | See SOW | 2 | $ - 0 | |||||
| 123 | (T) Retinoblastoma Protein (RB) | NEOGENOMICS | (T) Retinoblastoma Protein (RB) | See SOW | 3 | $ - 0 | |||||
| 124 | (T) S100 | NEOGENOMICS | (T) S100 | See SOW | 6 | $ - 0 | |||||
| 125 | (T) SATB2 | NEOGENOMICS | (T) SATB2 | See SOW | 3 | $ - 0 | |||||
| 126 | (T) SMA | NEOGENOMICS | (T) SMA | See SOW | 2 | $ - 0 | |||||
| 127 | (T) SMMHC | NEOGENOMICS | (T) SMMHC | See SOW | 2 | $ - 0 | |||||
| 128 | (T) Somatostatin Receptor, Type 2 | NEOGENOMICS | (T) Somatostatin Receptor, Type 2 | See SOW | 3 | $ - 0 | |||||
| 129 | (T) SOX10 | NEOGENOMICS | (T) SOX10 | See SOW | 2 | $ - 0 | |||||
| 130 | (T) SOX11 | NEOGENOMICS | (T) SOX11 | See SOW | 3 | $ - 0 | |||||
| 131 | (T) Spirochete | NEOGENOMICS | (T) Spirochete | See SOW | 4 | $ - 0 | |||||
| 132 | (T) STAT6 | NEOGENOMICS | (T) STAT6 | See SOW | 5 | $ - 0 | |||||
| 133 | (T) Synaptophysin | NEOGENOMICS | (T) Synaptophysin | See SOW | 2 | $ - 0 | |||||
| 134 | (T) TCL1 | NEOGENOMICS | (T) TCL1 | See SOW | 4 | $ - 0 | |||||
| 135 | (T) TdT | NEOGENOMICS | (T) TdT | See SOW | 6 | $ - 0 | |||||
| 136 | (T) TIA1 | NEOGENOMICS | (T) TIA1 | See SOW | 3 | $ - 0 | |||||
| 137 | (T) TLE1 | NEOGENOMICS | (T) TLE1 | See SOW | 2 | $ - 0 | |||||
| 138 | (T) Toxoplasma | NEOGENOMICS | (T) Toxoplasma | See SOW | 2 | $ - 0 | |||||
| 139 | (T) Trichrome | NEOGENOMICS | (T) Trichrome | See SOW | 4 | $ - 0 | |||||
| 140 | (T) Tryptase | NEOGENOMICS | (T) Tryptase | See SOW | 4 | $ - 0 | |||||
| 141 | (T) TTF1 | NEOGENOMICS | (T) TTF1 | See SOW | 6 | $ - 0 | |||||
| 142 | (T) Uroplakin II | NEOGENOMICS | (T) Uroplakin II | See SOW | 2 | $ - 0 | |||||
| 143 | (T) Uroplakin III | NEOGENOMICS | (T) Uroplakin III | See SOW | 2 | $ - 0 | |||||
| 144 | (T) Villin | NEOGENOMICS | (T) Villin | See SOW | 2 | $ - 0 | |||||
| 145 | (T) WT1 | NEOGENOMICS | (T) WT1 | See SOW | 8 | $ - 0 | |||||
| 146 | (P) NeoTYPE® ALL Profile (Molecular Only) | NEOGENOMICS | (P) NeoTYPE® ALL Profile (Molecular Only) | See SOW | 2 | $ - 0 | |||||
| 147 | (P) Sarcoma Comprehensive NGS Fusion Panel | NEOGENOMICS | (P) Sarcoma Comprehensive NGS Fusion Panel | See SOW | 2 | $ - 0 | |||||
| 148 | (T) B-Cell Gene Rearrangement | NEOGENOMICS | (T) B-Cell Gene Rearrangement | See SOW | 3 | $ - 0 | |||||
| 149 | (T) CXCR4 Mutation Analysis | NEOGENOMICS | (T) CXCR4 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 150 | (T) MLH1 Promoter Methylation Analysis | NEOGENOMICS | (T) MLH1 Promoter Methylation Analysis | See SOW | 2 | $ - 0 | |||||
| 151 | (T) MYD88 Mutation Analysis | NEOGENOMICS | (T) MYD88 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 152 | (T) T-Cell Receptor Beta Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Beta Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 153 | (T) T-Cell Receptor Gamma Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Gamma Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 154 | Calcium stain | NEOGENOMICS | Calcium stain | See SOW | 11 | $ - 0 | |||||
| 155 | MLH1 Qualitative | NEOGENOMICS | MLH1 Qualitative | See SOW | 3 | $ - 0 | |||||
| 156 | MSH6 Qualitative | NEOGENOMICS | MSH6 Qualitative | See SOW | 3 | $ - 0 | |||||
| 157 | Periodic Acid Schiff for Fungus (PASF) | NEOGENOMICS | Periodic Acid Schiff for Fungus (PASF) | See SOW | 12 | $ - 0 | |||||
| $ - 0 | |||||||||||
| Total | $ - 0 |
4. Option 3
| CLIN | Brand Name | Brand Name Nomenclature | Manufacturer Part Number | Salient Characteristics | Equivalent Brand | Equivalent Nomenclature | Equivalent Part Number | Equivalent Description Matching Salient Characteristics and/or location of information regarding equal capability | Quantity | Unit Price | Extended Price |
| 1 | (T) DDIT3 (CHOP)(12q13) | NEOGENOMICS | (T) DDIT3 (CHOP)(12q13) | See SOW | 2 | $ - 0 | |||||
| 2 | (T) H&E | NEOGENOMICS | (T) H&E | See SOW | 11 | $ - 0 | |||||
| 3 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 3 | $ - 0 | |||||
| 4 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 5 | (T) MDM2 | NEOGENOMICS | (T) MDM2 | See SOW | 8 | $ - 0 | |||||
| 6 | (P) AML MRD Flow Panel | NEOGENOMICS | (P) AML MRD Flow Panel | See SOW | 2 | $ - 0 | |||||
| 7 | (P) Amyloid A & P | NEOGENOMICS | (P) Amyloid A & P | See SOW | 3 | $ - 0 | |||||
| 8 | (P) Breast Panel (2 Stain) | NEOGENOMICS | (P) Breast Panel (2 Stain) | See SOW | 4 | $ - 0 | |||||
| 9 | (P) Breast Panel (3 Stain) | NEOGENOMICS | (P) Breast Panel (3 Stain) | See SOW | 4 | $ - 0 | |||||
| 10 | (P) Breast Panel (4 Stain) | NEOGENOMICS | (P) Breast Panel (4 Stain) | See SOW | 2 | $ - 0 | |||||
| 11 | (P) HPV RNA ISH Panel | NEOGENOMICS | (P) HPV RNA ISH Panel | See SOW | 8 | $ - 0 | |||||
| 12 | (P) Mismatch Repair (MMR) IHC Panel Qualitative | NEOGENOMICS | (P) Mismatch Repair (MMR) IHC Panel Qualitative | See SOW | 3 | $ - 0 | |||||
| 13 | (T) AFP | NEOGENOMICS | (T) AFP | See SOW | 4 | $ - 0 | |||||
| 14 | (T) Albumin RNA ISH | NEOGENOMICS | (T) Albumin RNA ISH | See SOW | 3 | $ - 0 | |||||
| 15 | (T) ALK (D5F3) | NEOGENOMICS | (T) ALK (D5F3) | See SOW | 4 | $ - 0 | |||||
| 16 | (T) ALK-1 (for Heme cases) | NEOGENOMICS | (T) ALK-1 (for Heme cases) | See SOW | 17 | $ - 0 | |||||
| 17 | (T) AR | NEOGENOMICS | (T) AR | See SOW | 2 | $ - 0 | |||||
| 18 | (T) AR Qualitative | NEOGENOMICS | (T) AR Qualitative | See SOW | 2 | $ - 0 | |||||
| 19 | (T) Arginase 1 | NEOGENOMICS | (T) Arginase 1 | See SOW | 12 | $ - 0 | |||||
| 20 | (T) BOB1 | NEOGENOMICS | (T) BOB1 | See SOW | 2 | $ - 0 | |||||
| 21 | (T) CA19.9 | NEOGENOMICS | (T) CA19.9 | See SOW | 2 | $ - 0 | |||||
| 22 | (T) Calcitonin | NEOGENOMICS | (T) Calcitonin | See SOW | 2 | $ - 0 | |||||
| 23 | (T) Calponin | NEOGENOMICS | (T) Calponin | See SOW | 2 | $ - 0 | |||||
| 24 | (T) Calretinin | NEOGENOMICS | (T) Calretinin | See SOW | 2 | $ - 0 | |||||
| 25 | (T) CD1a | NEOGENOMICS | (T) CD1a | See SOW | 3 | $ - 0 | |||||
| 26 | (T) CD2 | NEOGENOMICS | (T) CD2 | See SOW | 2 | $ - 0 | |||||
| 27 | (T) CD14 | NEOGENOMICS | (T) CD14 | See SOW | 2 | $ - 0 | |||||
| 28 | (T) CD15 | NEOGENOMICS | (T) CD15 | See SOW | 2 | $ - 0 | |||||
| 29 | (T) CD23 | NEOGENOMICS | (T) CD23 | See SOW | 4 | $ - 0 | |||||
| 30 | (T) CD25 | NEOGENOMICS | (T) CD25 | See SOW | 4 | $ - 0 | |||||
| 31 | (T) CD33 | NEOGENOMICS | (T) CD33 | See SOW | 2 | $ - 0 | |||||
| 32 | (T) CD42b | NEOGENOMICS | (T) CD42b | See SOW | 4 | $ - 0 | |||||
| 33 | (T) CD44 | NEOGENOMICS | (T) CD44 | See SOW | 5 | $ - 0 | |||||
| 34 | (T) CD61 | NEOGENOMICS | (T) CD61 | See SOW | 9 | $ - 0 | |||||
| 35 | (T) CD71 | NEOGENOMICS | (T) CD71 | See SOW | 4 | $ - 0 | |||||
| 36 | (T) CD79a | NEOGENOMICS | (T) CD79a | See SOW | 7 | $ - 0 | |||||
| 37 | (T) CD117 cKIT | NEOGENOMICS | (T) CD117 cKIT | See SOW | 3 | $ - 0 | |||||
| 38 | (T) CD123 | NEOGENOMICS | (T) CD123 | See SOW | 8 | $ - 0 | |||||
| 39 | (T) CD163 | NEOGENOMICS | (T) CD163 | See SOW | 3 | $ - 0 | |||||
| 40 | (T) CEA (Poly) | NEOGENOMICS | (T) CEA (Poly) | See SOW | 3 | $ - 0 | |||||
| 41 | (T) CK 7 | NEOGENOMICS | (T) CK 7 | See SOW | 7 | $ - 0 | |||||
| 42 | (T) CK 19 | NEOGENOMICS | (T) CK 19 | See SOW | 9 | $ - 0 | |||||
| 43 | (T) CK OSCAR | NEOGENOMICS | (T) CK OSCAR | See SOW | 7 | $ - 0 | |||||
| 44 | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | NEOGENOMICS | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | See SOW | 3 | $ - 0 | |||||
| 45 | (T) CMV by IHC | NEOGENOMICS | (T) CMV by IHC | See SOW | 28 | $ - 0 | |||||
| 46 | (T) cMyc | NEOGENOMICS | (T) cMyc | See SOW | 5 | $ - 0 | |||||
| 47 | (T) Congo Red | NEOGENOMICS | (T) Congo Red | See SOW | 3 | $ - 0 | |||||
| 48 | (T) CXCL13 | NEOGENOMICS | (T) CXCL13 | See SOW | 4 | $ - 0 | |||||
| 49 | (T) Desmin | NEOGENOMICS | (T) Desmin | See SOW | 2 | $ - 0 | |||||
| 50 | (T) DOG1 | NEOGENOMICS | (T) DOG1 | See SOW | 3 | $ - 0 | |||||
| 51 | (T) E-Cadherin | NEOGENOMICS | (T) E-Cadherin | See SOW | 6 | $ - 0 | |||||
| 52 | (T) EBER ISH | NEOGENOMICS | (T) EBER ISH | See SOW | 26 | $ - 0 | |||||
| 53 | (T) EBV (LMP1) | NEOGENOMICS | (T) EBV (LMP1) | See SOW | 2 | $ - 0 | |||||
| 54 | (T) Elastic Stain | NEOGENOMICS | (T) Elastic Stain | See SOW | 3 | $ - 0 | |||||
| 55 | (T) ER | NEOGENOMICS | (T) ER | See SOW | 3 | $ - 0 | |||||
| 56 | (T) ER Qualitative | NEOGENOMICS | (T) ER Qualitative | See SOW | 8 | $ - 0 | |||||
| 57 | (T) ERG | NEOGENOMICS | (T) ERG | See SOW | 7 | $ - 0 | |||||
| 58 | (T) Factor XIIIa | NEOGENOMICS | (T) Factor XIIIa | See SOW | 2 | $ - 0 | |||||
| 59 | (T) Fli-1 | NEOGENOMICS | (T) Fli-1 | See SOW | 2 | $ - 0 | |||||
| 60 | (T) Gastrin | NEOGENOMICS | (T) Gastrin | See SOW | 5 | $ - 0 | |||||
| 61 | (T) GCDFP15 | NEOGENOMICS | (T) GCDFP15 | See SOW | 2 | $ - 0 | |||||
| 62 | (T) Glypican-3 | NEOGENOMICS | (T) Glypican-3 | See SOW | 12 | $ - 0 | |||||
| 63 | (T) GMS | NEOGENOMICS | (T) GMS | See SOW | 12 | $ - 0 | |||||
| 64 | (T) Gram Stain | NEOGENOMICS | (T) Gram Stain | See SOW | 8 | $ - 0 | |||||
| 65 | (T) Granzyme B | NEOGENOMICS | (T) Granzyme B | See SOW | 4 | $ - 0 | |||||
| 66 | (T) H3K27me3 | NEOGENOMICS | (T) H3K27me3 | See SOW | 2 | $ - 0 | |||||
| 67 | (T) H. Pylori | NEOGENOMICS | (T) H. Pylori | See SOW | 7 | $ - 0 | |||||
| 68 | (T) HCG Beta | NEOGENOMICS | (T) HCG Beta | See SOW | 2 | $ - 0 | |||||
| 69 | (T) HER2 (Other) – with Breast Scoring | NEOGENOMICS | (T) HER2 (Other) – with Breast Scoring | See SOW | 7 | $ - 0 | |||||
| 70 | (T) HER2 (Other) – with Gastric Scoring | NEOGENOMICS | (T) HER2 (Other) – with Gastric Scoring | See SOW | 2 | $ - 0 | |||||
| 71 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 5 | $ - 0 | |||||
| 72 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 10 | $ - 0 | |||||
| 73 | (T) HHV8 | NEOGENOMICS | (T) HHV8 | See SOW | 11 | $ - 0 | |||||
| 74 | (T) Histology Other | NEOGENOMICS | (T) Histology Other | See SOW | 5 | $ - 0 | |||||
| 75 | (T) HMB45 | NEOGENOMICS | (T) HMB45 | See SOW | 2 | $ - 0 | |||||
| 76 | (T) HPV RNA ISH High Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH High Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 77 | (T) HPV RNA ISH Low Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH Low Risk Cocktail | See SOW | 9 | $ - 0 | |||||
| 78 | (T) HSV1/2 | NEOGENOMICS | (T) HSV1/2 | See SOW | 11 | $ - 0 | |||||
| 79 | (T) ICOS | NEOGENOMICS | (T) ICOS | See SOW | 3 | $ - 0 | |||||
| 80 | (T) Ig G | NEOGENOMICS | (T) Ig G | See SOW | 11 | $ - 0 | |||||
| 81 | (T) IgG4 | NEOGENOMICS | (T) IgG4 | See SOW | 11 | $ - 0 | |||||
| 82 | (T) Inhibin | NEOGENOMICS | (T) Inhibin | See SOW | 2 | $ - 0 | |||||
| 83 | (T) INI1 | NEOGENOMICS | (T) INI1 | See SOW | 2 | $ - 0 | |||||
| 84 | (T) INSM1 | NEOGENOMICS | (T) INSM1 | See SOW | 4 | $ - 0 | |||||
| 85 | (T) Ki67 | NEOGENOMICS | (T) Ki67 | See SOW | 3 | $ - 0 | |||||
| 86 | (T) Langerin | NEOGENOMICS | (T) Langerin | See SOW | 2 | $ - 0 | |||||
| 87 | (T) LEF1 | NEOGENOMICS | (T) LEF1 | See SOW | 2 | $ - 0 | |||||
| 88 | (T) LMO2 | NEOGENOMICS | (T) LMO2 | See SOW | 2 | $ - 0 | |||||
| 89 | (T) Mammaglobin | NEOGENOMICS | (T) Mammaglobin | See SOW | 5 | $ - 0 | |||||
| 90 | (T) MPO | NEOGENOMICS | (T) MPO | See SOW | 4 | $ - 0 | |||||
| 91 | (T) MSH2 Qualitative | NEOGENOMICS | (T) MSH2 Qualitative | See SOW | 3 | $ - 0 | |||||
| 92 | (T) MUC1 | NEOGENOMICS | (T) MUC1 | See SOW | 2 | $ - 0 | |||||
| 93 | (T) MUC2 | NEOGENOMICS | (T) MUC2 | See SOW | 2 | $ - 0 | |||||
| 94 | (T) MUC5 | NEOGENOMICS | (T) MUC5 | See SOW | 2 | $ - 0 | |||||
| 95 | (T) MUC6 | NEOGENOMICS | (T) MUC6 | See SOW | 2 | $ - 0 | |||||
| 96 | (T) MUM1 | NEOGENOMICS | (T) MUM1 | See SOW | 19 | $ - 0 | |||||
| 97 | (T) NF (Neurofilament) | NEOGENOMICS | (T) NF (Neurofilament) | See SOW | 2 | $ - 0 | |||||
| 98 | (T) NKX2.2 | NEOGENOMICS | (T) NKX2.2 | See SOW | 2 | $ - 0 | |||||
| 99 | (T) NKX3.1 | NEOGENOMICS | (T) NKX3.1 | See SOW | 3 | $ - 0 | |||||
| 100 | (T) OCT2 | NEOGENOMICS | (T) OCT2 | See SOW | 3 | $ - 0 | |||||
| 101 | (T) OCT4 | NEOGENOMICS | (T) OCT4 | See SOW | 4 | $ - 0 | |||||
| 102 | (T) p40 | NEOGENOMICS | (T) p40 | See SOW | 2 | $ - 0 | |||||
| 103 | (T) P63 | NEOGENOMICS | (T) P63 | See SOW | 2 | $ - 0 | |||||
| 104 | (T) P504S | NEOGENOMICS | (T) P504S | See SOW | 2 | $ - 0 | |||||
| 105 | (T) Pan-Cytokeratin | NEOGENOMICS | (T) Pan-Cytokeratin | See SOW | 7 | $ - 0 | |||||
| 106 | (T) PAS | NEOGENOMICS | (T) PAS | See SOW | 2 | $ - 0 | |||||
| 107 | (T) PAX2 | NEOGENOMICS | (T) PAX2 | See SOW | 2 | $ - 0 | |||||
| 108 | (T) PAX5 | NEOGENOMICS | (T) PAX5 | See SOW | 5 | $ - 0 | |||||
| 109 | (T) PD1 | NEOGENOMICS | (T) PD1 | See SOW | 6 | $ - 0 | |||||
| 110 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 111 | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | NEOGENOMICS | (T) PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head and Neck) | See SOW | 12 | $ - 0 | |||||
| 112 | (T) PD-L1 22C3 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 22C3 FDA for NSCLC | See SOW | 66 | $ - 0 | |||||
| 113 | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | NEOGENOMICS | (T) PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC | See SOW | 7 | $ - 0 | |||||
| 114 | (T) PD-L1 28-8 FDA for NSCLC | NEOGENOMICS | (T) PD-L1 28-8 FDA for NSCLC | See SOW | 3 | $ - 0 | |||||
| 115 | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | NEOGENOMICS | (T) PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC | See SOW | 2 | $ - 0 | |||||
| 116 | (T) Periodic Acid Schiff with Digestion (PASD) | NEOGENOMICS | (T) Periodic Acid Schiff with Digestion (PASD) | See SOW | 5 | $ - 0 | |||||
| 117 | (T) PgR | NEOGENOMICS | (T) PgR | See SOW | 3 | $ - 0 | |||||
| 118 | (T) PLAP | NEOGENOMICS | (T) PLAP | See SOW | 2 | $ - 0 | |||||
| 119 | (T) PMS2 | NEOGENOMICS | (T) PMS2 | See SOW | 7 | $ - 0 | |||||
| 120 | (T) PMS2 Qualitative | NEOGENOMICS | (T) PMS2 Qualitative | See SOW | 26 | $ - 0 | |||||
| 121 | (T) PSA | NEOGENOMICS | (T) PSA | See SOW | 2 | $ - 0 | |||||
| 122 | (T) PTH | NEOGENOMICS | (T) PTH | See SOW | 2 | $ - 0 | |||||
| 123 | (T) Retinoblastoma Protein (RB) | NEOGENOMICS | (T) Retinoblastoma Protein (RB) | See SOW | 3 | $ - 0 | |||||
| 124 | (T) S100 | NEOGENOMICS | (T) S100 | See SOW | 6 | $ - 0 | |||||
| 125 | (T) SATB2 | NEOGENOMICS | (T) SATB2 | See SOW | 3 | $ - 0 | |||||
| 126 | (T) SMA | NEOGENOMICS | (T) SMA | See SOW | 2 | $ - 0 | |||||
| 127 | (T) SMMHC | NEOGENOMICS | (T) SMMHC | See SOW | 2 | $ - 0 | |||||
| 128 | (T) Somatostatin Receptor, Type 2 | NEOGENOMICS | (T) Somatostatin Receptor, Type 2 | See SOW | 3 | $ - 0 | |||||
| 129 | (T) SOX10 | NEOGENOMICS | (T) SOX10 | See SOW | 2 | $ - 0 | |||||
| 130 | (T) SOX11 | NEOGENOMICS | (T) SOX11 | See SOW | 3 | $ - 0 | |||||
| 131 | (T) Spirochete | NEOGENOMICS | (T) Spirochete | See SOW | 4 | $ - 0 | |||||
| 132 | (T) STAT6 | NEOGENOMICS | (T) STAT6 | See SOW | 5 | $ - 0 | |||||
| 133 | (T) Synaptophysin | NEOGENOMICS | (T) Synaptophysin | See SOW | 2 | $ - 0 | |||||
| 134 | (T) TCL1 | NEOGENOMICS | (T) TCL1 | See SOW | 4 | $ - 0 | |||||
| 135 | (T) TdT | NEOGENOMICS | (T) TdT | See SOW | 6 | $ - 0 | |||||
| 136 | (T) TIA1 | NEOGENOMICS | (T) TIA1 | See SOW | 3 | $ - 0 | |||||
| 137 | (T) TLE1 | NEOGENOMICS | (T) TLE1 | See SOW | 2 | $ - 0 | |||||
| 138 | (T) Toxoplasma | NEOGENOMICS | (T) Toxoplasma | See SOW | 2 | $ - 0 | |||||
| 139 | (T) Trichrome | NEOGENOMICS | (T) Trichrome | See SOW | 4 | $ - 0 | |||||
| 140 | (T) Tryptase | NEOGENOMICS | (T) Tryptase | See SOW | 4 | $ - 0 | |||||
| 141 | (T) TTF1 | NEOGENOMICS | (T) TTF1 | See SOW | 6 | $ - 0 | |||||
| 142 | (T) Uroplakin II | NEOGENOMICS | (T) Uroplakin II | See SOW | 2 | $ - 0 | |||||
| 143 | (T) Uroplakin III | NEOGENOMICS | (T) Uroplakin III | See SOW | 2 | $ - 0 | |||||
| 144 | (T) Villin | NEOGENOMICS | (T) Villin | See SOW | 2 | $ - 0 | |||||
| 145 | (T) WT1 | NEOGENOMICS | (T) WT1 | See SOW | 8 | $ - 0 | |||||
| 146 | (P) NeoTYPE® ALL Profile (Molecular Only) | NEOGENOMICS | (P) NeoTYPE® ALL Profile (Molecular Only) | See SOW | 2 | $ - 0 | |||||
| 147 | (P) Sarcoma Comprehensive NGS Fusion Panel | NEOGENOMICS | (P) Sarcoma Comprehensive NGS Fusion Panel | See SOW | 2 | $ - 0 | |||||
| 148 | (T) B-Cell Gene Rearrangement | NEOGENOMICS | (T) B-Cell Gene Rearrangement | See SOW | 3 | $ - 0 | |||||
| 149 | (T) CXCR4 Mutation Analysis | NEOGENOMICS | (T) CXCR4 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 150 | (T) MLH1 Promoter Methylation Analysis | NEOGENOMICS | (T) MLH1 Promoter Methylation Analysis | See SOW | 2 | $ - 0 | |||||
| 151 | (T) MYD88 Mutation Analysis | NEOGENOMICS | (T) MYD88 Mutation Analysis | See SOW | 2 | $ - 0 | |||||
| 152 | (T) T-Cell Receptor Beta Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Beta Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 153 | (T) T-Cell Receptor Gamma Gene Rearrangement | NEOGENOMICS | (T) T-Cell Receptor Gamma Gene Rearrangement | See SOW | 6 | $ - 0 | |||||
| 154 | Calcium stain | NEOGENOMICS | Calcium stain | See SOW | 11 | $ - 0 | |||||
| 155 | MLH1 Qualitative | NEOGENOMICS | MLH1 Qualitative | See SOW | 3 | $ - 0 | |||||
| 156 | MSH6 Qualitative | NEOGENOMICS | MSH6 Qualitative | See SOW | 3 | $ - 0 | |||||
| 157 | Periodic Acid Schiff for Fungus (PASF) | NEOGENOMICS | Periodic Acid Schiff for Fungus (PASF) | See SOW | 12 | $ - 0 | |||||
| $ - 0 | |||||||||||
| Total | $ - 0 |
5. Option 4
| CLIN | Brand Name | Brand Name Nomenclature | Manufacturer Part Number | Salient Characteristics | Equivalent Brand | Equivalent Nomenclature | Equivalent Part Number | Equivalent Description Matching Salient Characteristics and/or location of information regarding equal capability | Quantity | Unit Price | Extended Price |
| 1 | (T) DDIT3 (CHOP)(12q13) | NEOGENOMICS | (T) DDIT3 (CHOP)(12q13) | See SOW | 2 | $ - 0 | |||||
| 2 | (T) H&E | NEOGENOMICS | (T) H&E | See SOW | 11 | $ - 0 | |||||
| 3 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 3 | $ - 0 | |||||
| 4 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 2 | $ - 0 | |||||
| 5 | (T) MDM2 | NEOGENOMICS | (T) MDM2 | See SOW | 8 | $ - 0 | |||||
| 6 | (P) AML MRD Flow Panel | NEOGENOMICS | (P) AML MRD Flow Panel | See SOW | 2 | $ - 0 | |||||
| 7 | (P) Amyloid A & P | NEOGENOMICS | (P) Amyloid A & P | See SOW | 3 | $ - 0 | |||||
| 8 | (P) Breast Panel (2 Stain) | NEOGENOMICS | (P) Breast Panel (2 Stain) | See SOW | 4 | $ - 0 | |||||
| 9 | (P) Breast Panel (3 Stain) | NEOGENOMICS | (P) Breast Panel (3 Stain) | See SOW | 4 | $ - 0 | |||||
| 10 | (P) Breast Panel (4 Stain) | NEOGENOMICS | (P) Breast Panel (4 Stain) | See SOW | 2 | $ - 0 | |||||
| 11 | (P) HPV RNA ISH Panel | NEOGENOMICS | (P) HPV RNA ISH Panel | See SOW | 8 | $ - 0 | |||||
| 12 | (P) Mismatch Repair (MMR) IHC Panel Qualitative | NEOGENOMICS | (P) Mismatch Repair (MMR) IHC Panel Qualitative | See SOW | 3 | $ - 0 | |||||
| 13 | (T) AFP | NEOGENOMICS | (T) AFP | See SOW | 4 | $ - 0 | |||||
| 14 | (T) Albumin RNA ISH | NEOGENOMICS | (T) Albumin RNA ISH | See SOW | 3 | $ - 0 | |||||
| 15 | (T) ALK (D5F3) | NEOGENOMICS | (T) ALK (D5F3) | See SOW | 4 | $ - 0 | |||||
| 16 | (T) ALK-1 (for Heme cases) | NEOGENOMICS | (T) ALK-1 (for Heme cases) | See SOW | 17 | $ - 0 | |||||
| 17 | (T) AR | NEOGENOMICS | (T) AR | See SOW | 2 | $ - 0 | |||||
| 18 | (T) AR Qualitative | NEOGENOMICS | (T) AR Qualitative | See SOW | 2 | $ - 0 | |||||
| 19 | (T) Arginase 1 | NEOGENOMICS | (T) Arginase 1 | See SOW | 12 | $ - 0 | |||||
| 20 | (T) BOB1 | NEOGENOMICS | (T) BOB1 | See SOW | 2 | $ - 0 | |||||
| 21 | (T) CA19.9 | NEOGENOMICS | (T) CA19.9 | See SOW | 2 | $ - 0 | |||||
| 22 | (T) Calcitonin | NEOGENOMICS | (T) Calcitonin | See SOW | 2 | $ - 0 | |||||
| 23 | (T) Calponin | NEOGENOMICS | (T) Calponin | See SOW | 2 | $ - 0 | |||||
| 24 | (T) Calretinin | NEOGENOMICS | (T) Calretinin | See SOW | 2 | $ - 0 | |||||
| 25 | (T) CD1a | NEOGENOMICS | (T) CD1a | See SOW | 3 | $ - 0 | |||||
| 26 | (T) CD2 | NEOGENOMICS | (T) CD2 | See SOW | 2 | $ - 0 | |||||
| 27 | (T) CD14 | NEOGENOMICS | (T) CD14 | See SOW | 2 | $ - 0 | |||||
| 28 | (T) CD15 | NEOGENOMICS | (T) CD15 | See SOW | 2 | $ - 0 | |||||
| 29 | (T) CD23 | NEOGENOMICS | (T) CD23 | See SOW | 4 | $ - 0 | |||||
| 30 | (T) CD25 | NEOGENOMICS | (T) CD25 | See SOW | 4 | $ - 0 | |||||
| 31 | (T) CD33 | NEOGENOMICS | (T) CD33 | See SOW | 2 | $ - 0 | |||||
| 32 | (T) CD42b | NEOGENOMICS | (T) CD42b | See SOW | 4 | $ - 0 | |||||
| 33 | (T) CD44 | NEOGENOMICS | (T) CD44 | See SOW | 5 | $ - 0 | |||||
| 34 | (T) CD61 | NEOGENOMICS | (T) CD61 | See SOW | 9 | $ - 0 | |||||
| 35 | (T) CD71 | NEOGENOMICS | (T) CD71 | See SOW | 4 | $ - 0 | |||||
| 36 | (T) CD79a | NEOGENOMICS | (T) CD79a | See SOW | 7 | $ - 0 | |||||
| 37 | (T) CD117 cKIT | NEOGENOMICS | (T) CD117 cKIT | See SOW | 3 | $ - 0 | |||||
| 38 | (T) CD123 | NEOGENOMICS | (T) CD123 | See SOW | 8 | $ - 0 | |||||
| 39 | (T) CD163 | NEOGENOMICS | (T) CD163 | See SOW | 3 | $ - 0 | |||||
| 40 | (T) CEA (Poly) | NEOGENOMICS | (T) CEA (Poly) | See SOW | 3 | $ - 0 | |||||
| 41 | (T) CK 7 | NEOGENOMICS | (T) CK 7 | See SOW | 7 | $ - 0 | |||||
| 42 | (T) CK 19 | NEOGENOMICS | (T) CK 19 | See SOW | 9 | $ - 0 | |||||
| 43 | (T) CK OSCAR | NEOGENOMICS | (T) CK OSCAR | See SOW | 7 | $ - 0 | |||||
| 44 | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | NEOGENOMICS | (T) Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma | See SOW | 3 | $ - 0 | |||||
| 45 | (T) CMV by IHC | NEOGENOMICS | (T) CMV by IHC | See SOW | 28 | $ - 0 | |||||
| 46 | (T) cMyc | NEOGENOMICS | (T) cMyc | See SOW | 5 | $ - 0 | |||||
| 47 | (T) Congo Red | NEOGENOMICS | (T) Congo Red | See SOW | 3 | $ - 0 | |||||
| 48 | (T) CXCL13 | NEOGENOMICS | (T) CXCL13 | See SOW | 4 | $ - 0 | |||||
| 49 | (T) Desmin | NEOGENOMICS | (T) Desmin | See SOW | 2 | $ - 0 | |||||
| 50 | (T) DOG1 | NEOGENOMICS | (T) DOG1 | See SOW | 3 | $ - 0 | |||||
| 51 | (T) E-Cadherin | NEOGENOMICS | (T) E-Cadherin | See SOW | 6 | $ - 0 | |||||
| 52 | (T) EBER ISH | NEOGENOMICS | (T) EBER ISH | See SOW | 26 | $ - 0 | |||||
| 53 | (T) EBV (LMP1) | NEOGENOMICS | (T) EBV (LMP1) | See SOW | 2 | $ - 0 | |||||
| 54 | (T) Elastic Stain | NEOGENOMICS | (T) Elastic Stain | See SOW | 3 | $ - 0 | |||||
| 55 | (T) ER | NEOGENOMICS | (T) ER | See SOW | 3 | $ - 0 | |||||
| 56 | (T) ER Qualitative | NEOGENOMICS | (T) ER Qualitative | See SOW | 8 | $ - 0 | |||||
| 57 | (T) ERG | NEOGENOMICS | (T) ERG | See SOW | 7 | $ - 0 | |||||
| 58 | (T) Factor XIIIa | NEOGENOMICS | (T) Factor XIIIa | See SOW | 2 | $ - 0 | |||||
| 59 | (T) Fli-1 | NEOGENOMICS | (T) Fli-1 | See SOW | 2 | $ - 0 | |||||
| 60 | (T) Gastrin | NEOGENOMICS | (T) Gastrin | See SOW | 5 | $ - 0 | |||||
| 61 | (T) GCDFP15 | NEOGENOMICS | (T) GCDFP15 | See SOW | 2 | $ - 0 | |||||
| 62 | (T) Glypican-3 | NEOGENOMICS | (T) Glypican-3 | See SOW | 12 | $ - 0 | |||||
| 63 | (T) GMS | NEOGENOMICS | (T) GMS | See SOW | 12 | $ - 0 | |||||
| 64 | (T) Gram Stain | NEOGENOMICS | (T) Gram Stain | See SOW | 8 | $ - 0 | |||||
| 65 | (T) Granzyme B | NEOGENOMICS | (T) Granzyme B | See SOW | 4 | $ - 0 | |||||
| 66 | (T) H3K27me3 | NEOGENOMICS | (T) H3K27me3 | See SOW | 2 | $ - 0 | |||||
| 67 | (T) H. Pylori | NEOGENOMICS | (T) H. Pylori | See SOW | 7 | $ - 0 | |||||
| 68 | (T) HCG Beta | NEOGENOMICS | (T) HCG Beta | See SOW | 2 | $ - 0 | |||||
| 69 | (T) HER2 (Other) – with Breast Scoring | NEOGENOMICS | (T) HER2 (Other) – with Breast Scoring | See SOW | 7 | $ - 0 | |||||
| 70 | (T) HER2 (Other) – with Gastric Scoring | NEOGENOMICS | (T) HER2 (Other) – with Gastric Scoring | See SOW | 2 | $ - 0 | |||||
| 71 | (T) HER2 Breast | NEOGENOMICS | (T) HER2 Breast | See SOW | 5 | $ - 0 | |||||
| 72 | (T) HER2 Gastric/GEA | NEOGENOMICS | (T) HER2 Gastric/GEA | See SOW | 10 | $ - 0 | |||||
| 73 | (T) HHV8 | NEOGENOMICS | (T) HHV8 | See SOW | 11 | $ - 0 | |||||
| 74 | (T) Histology Other | NEOGENOMICS | (T) Histology Other | See SOW | 5 | $ - 0 | |||||
| 75 | (T) HMB45 | NEOGENOMICS | (T) HMB45 | See SOW | 2 | $ - 0 | |||||
| 76 | (T) HPV RNA ISH High Risk Cocktail | NEOGENOMICS | (T) HPV RNA ISH High Risk Cocktail | See SOW | 9 | $ - 0 |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .